Lv1
90 积分 2023-02-27 加入
Usefulness of the PRECISE-DAPT score at differentiating between ticagrelor and prasugrel for dual antiplatelet therapy initiation
4个月前
已完结
2018 update of expert consensus statement on antiplatelet therapy in East Asian patients with ACS or undergoing PCI
8个月前
已完结
Ticagrelor–Aspirin Versus Clopidogrel–Aspirin Among CYP2C19 Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial
10个月前
已完结
Contemporary Use of Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
11个月前
已完结
Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention
11个月前
已完结
Defining Overweight and Obesity by Percent Body Fat instead of Body Mass Index
11个月前
已完结
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score
11个月前
已完结
Prognostic Value of Cardiovascular Biomarkers in the Population
11个月前
已完结
Cardiovascular-Kidney-Metabolic Syndrome: Association with Adverse Events After Major Noncardiac Surgery
11个月前
已完结
High Lipoprotein(a) May Increase CVD Risk Even Without Inflammation
1年前
已完结
皖公网安备34019202002308
